CSX vs RTX

CSX presents a significant valuation disconnect, with a Piotroski F-Score of 4/9 indicating only stable health and a current price of $43.37 that vastly exceeds both the Graham Number ($15.61) and Intrinsic Value ($10.71). While the company maintains strong operating margins (32.72%) and ROE (22.51%), growth has stalled with negative YoY revenue and earnings growth. The stock has experienced a massive 1-year price surge of 60.3%, yet the technical trend has shifted to heavily bearish (10/100), suggesting a potential peak. Overall, the high PEG ratio of 3.74 indicates the market is paying a steep premium for a company with stagnant growth.

RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.